Remicade (infliximab) - J&J
Taltz (ixekizumab) - Eli Lilly, Japan Tobacco
Bimzelx (bimekizumab-bkzx) - UCB
Cimzia (certolizumab pegol) - Astellas, UCB
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
methotrexate - Generic mfg.
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Cosentyx (secukinumab) - Novartis
Stelara (ustekinumab) - J&J
cyclosporine - Generic mfg.
Jinlixi (xeligekimab) - Zhixiang (Shanghai) Pharma
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
Siliq (brodalumab) - Bausch Health
apremilast - Generic mfg.
Sotyktu (deucravacitinib) - BMS
Enbrel (etanercept) - Pfizer, Amgen
http://www.ncbi.nlm.nih.gov/pubmed/40767824
 
Alexia Mubuanga Nkusu; Anna Chaimani; Camille Ollivier; Carolyn Hughes; Cheng-Chen Tai; Cherry Choudhary; Emilie Sbidian; Laurence Le Cleach; Quentin Beytout; Quentin Samaran; Robin Guelimi; Sivem Afach
 
Aug 6, 2025
 
Next